You Searched For "Zydus Lifesciences stock price" and got 13 results
Sort By:
1 min read
Zydus Lifesciences acquires UK-based LiqMeds Group for GBP 68 million
LiqMeds Group of companies specialises in the development, manufacturing and supply of oral liq…
PTI
1 min read
Zydus Q4 net profit surges 4-fold to ₹1,182 cr; revenue at ₹5,534 cr
Revenue from operations rose to Rs 5,534 crore in the period under review from Rs 5,011 crore i…
PTI
1 min read
Zydus Lifesciences Q1 2023-24 profit up 2-fold at Rs 1,087 cr
Revenue from operations during the quarter under review stood at Rs 5,139.6 crore as against Rs…
PTI
2 mins read
Supriya Lifescience IPO: Here’s how you can check the allotment status
The Mumbai-based active pharmaceuticals ingredients (APIs) manufacturer, Supriya Lifescience, is li…
2 mins read
Supriya Lifescience beats IPO investors expectations and debuts with 55% premium
The Mumbai-based active pharmaceutical ingredients (APIs) manufacturer, Supriya Lifescience made a …
1 min read
Obalon Therapeutics skyrockets 568% after announcing merger with weight-loss company ReShape Lifesciences
Trading volume for Obalon Therapeutics exploded on news it will merge with weight-loss company ReSh…
Emily Graffeo
3 mins read
Top stock movers — Tata Motors, SBI Cards, Cochin Shipyard, Zydus Cadila, Cipla, Dr Reddy’s, MphasiS, and others
Indian stock market indices opened on a higher note on Friday, tracking gains in index majors HDFC …
2 mins read
Top stocks to watch — Cipla, Zydus Cadila, Dr Reddy Laboratories, Tech Mahindra, Avenue Supermarts, Cochin Shipyard, and others
Amidst mixed cues from the global markets, the Indian equities are likely to open flat on Friday. T…
2 mins read
Top stocks to watch— TCS, Future Consumer, ONGC, Zydus Wellness, HDFC, IL&FS, Angel Broking, Sun Pharma and others
The Indian stock market is likely to open in red on Thursday, amid the weak sentiments from the glo…
5 mins read
Analysts suggest subscribing to this pharma company IPO on discounted valuation and strong product portfolio than peers
Amid myriad initial public offerings (IPO) going on, here is another one worth giving attention to,…
4 mins read
Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients
The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…
2 mins read
Greenwich LifeSciences rockets 2,941% in a single day after encouraging phase 2 data on breast cancer treatment
Greenwich LifeSciences went public in September at an IPO price of $5.75, raising the firm $7.25 mi…